Breakthrough Gate Fidelities and Gate Speed
Achieved 2-qubit gate fidelity as high as 99.9% at a 28 ns gate speed (Adiabatic CZ on ProDrive); maintained 1-qubit gate fidelity at 99.9%. Reported median 2-qubit fidelities of 99.7% (9-qubit), 99.6% (36-qubit) and 99% (108-qubit Cepheus-1-108Q). Company expects to deploy the 108-qubit system with ~99.5% median 2-qubit fidelity by end of March 2026 and targets >150 qubits at ~99.7% median 2-qubit fidelity by end of December 2026, and >1,000 qubits at ~99.8% median 2-qubit fidelity by ~end of 2027.
Chiplet Architecture Demonstrated and Fab 1 Competitive Advantage
Successfully deployed multiple systems to the cloud (including an 84-qubit monolithic chip system and a 36-qubit chiplet base system) and demonstrated that chiplet timing works in practice. Operates Fab 1 (integrated quantum device manufacturing facility) enabling tight design-fabrication-testing cycles and providing a durable competitive advantage for scaling beyond 100 qubits.
Notable Commercial Orders and Geographic Expansion
Secured an $8.4M order from India's C-DAC for a 108-qubit on-premises system (scheduled H2 2026). Announced ~ $5.7M in purchase orders for two upgradeable 9-qubit Novera on-premises systems (expected to drive Q1–Q2 2026 revenue recognition). Secured a Novera QPU order from a Japanese research organization (delivery expected April 2026) — Rigetti's first QPU in Japan.
Strategic Partnerships and Ecosystem Integrations
Expanded collaborations with Riverlane (real-time quantum error correction), NVIDIA (NVQLink / hybrid quantum-AI integration), QphoX (optical readout research), Quanta Computer (controls), and others. These partnerships support error correction, hybrid workflows and integration with AI/HPC ecosystems (e.g., CUDA Quantum / NVQLink).
Strengthened Balance Sheet and Runway
Ended 2025 with approximately $590M in cash, cash equivalents and available-for-sale investments versus ~$217M at end of 2024, and no debt — providing runway and flexibility to execute the multi-year roadmap toward quantum advantage.
Improved Non-GAAP Loss and Clear Revenue Recognition Guidance
Non-GAAP net loss improved to $11.3M (−19.3% vs. prior-year quarter $14.0M) or $0.03 per share (vs. $0.06 prior-year). Management provided timing guidance: less than half of the $5.7M Novera revenue expected in Q1 2026 with remainder in Q2 2026; C-DAC $8.4M recognized at point-in-time upon H2 2026 validation. Company expects significant Q1 year-over-year revenue growth driven by Novera shipments.